Filing Details
- Accession Number:
- 0001140361-10-014529
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-31 13:00:00
- Reporting Period:
- 2010-03-29
- Filing Date:
- 2010-03-31
- Accepted Time:
- 2010-03-31 17:12:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1010086 | Siga Technologies Inc | SIGA | Pharmaceutical Preparations (2834) | 133864870 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1301548 | E Dennis Hruby | C/O Siga Technologies, Inc. 35 East 62Nd Street New York, NY 10065 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.0001 Per Share | Disposition | 2010-03-29 | 67,018 | $6.78 | 857,982 | No | 4 | S | Direct | |
| Common Stock, Par Value $.0001 Per Share | Disposition | 2010-03-30 | 57,982 | $6.51 | 800,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.65 to $7.02, inclusive. The reporting person undertakes to provide to SIGA Technologies, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.41 to $6.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Includes 857,982 shares of common stock issuable upon the exercise of options.
- Includes 800,000 shares of common stock issuable upon the exercise of options.
Billionaire Hedge Funds
